201.7K
Downloads
284
Episodes
Hosted by Ryan Irvine & Aaron Dunn, the podcast is highly interactive taking listener questions each week on individual Canadian & U.S. stocks as well as stock portfolio building strategies. The podcast focuses on high quality Canadian Dividend growth stocks, unknown & profitable Canadian Small-Cap stocks, U.S. tech leaders and high growth small-cap stocks. We also provide simple portfolio building tips for DIY investors. Weekly show highlights include: - Case For & Against Any Stock: our Ryan, Aaron & Brennan debate the pro's & con's of investing in a stock from a fundamental perspective and one of our analysts acts as judge, jury, and executioner to settle the lively debate. -Your Stock, Our Take Segment: Need a sober second opinion on any stock in your portfolio? Send a question to our Your Stock Our Take segment and we will review the business based on our BUY/SELL/HOLD criteria. - DIY Portfolio Building Tips: Interested in building your own DIY stock portfolio while paying less fees? Listen-in every week to uncover tips on how to take control of your financial future and dissect the hot button topics and stocks of the week. - Dividend Growth Stocks & Profitable Unknown Small-Caps: KeyStone’s Stock Talk Podcast is the only podcast talking Canadian & U.S. stocks across all market sectors. From profitable, unknown small-caps to great dividend paying mid and large caps, it is they type of stock discussion you can find nowhere else. - Canadian Stock Content: For Canadian investors & created by Canadian investors, we actually talk Canadian stocks. Real stocks to add to your watch list and, perhaps most importantly, which stocks to potentially avoid. - Hot Topics: From the FAANGs, AI, SaaS, cloud computing, and cybersecurity to gold, Cannabis, renewable & alternative energy to day trading vs. long-term investing, we have you covered.
Episodes
Wednesday Mar 24, 2021
Wednesday Mar 24, 2021
We have a busy show for you this week – in Our Case For / Case Against debate we take a look at Skylight Health Group Inc (SHG:TSX-V), which owns and operates a proprietary virtual telehealth platform, and a network of over 30 medical clinics across 16 states in the US, providing integrative, primary, and urgent care services to over 155,000 patients annually.
In our Your Stock, Our Take Segment, we answer a listener question on the very topical AstraZeneca PLC (AZN:NASDAQ), the British-Swedish multinational pharmaceutical and biotechnology company now best known for developing one of the 3 covid-19 vaccines approved for use in Europe. The vaccine is also approved for use in Canada but, to date, not in the United States. We let you know how the business looks from a fundamental perspective and if it is an opportunity or one to avoid.
Comments (0)
To leave or reply to comments, please download free Podbean or
No Comments
To leave or reply to comments,
please download free Podbean App.